Creating a New Paradigm in Precision Medicine for The Company Fulgent Pharma Holdings, Inc., an independent clinical-stage, therapeutics development company focused on the development of cutting-edge cancer treatments, has been acquired by Fulgent Genetics, Inc., a technology-based genetic testing business focused on transforming patient care in oncology, infectious and rare […]
Hitesh
Ascensia Diabetes Care Announces Global Integration Of The Eversense CGM System With Apple Health
Ascensia Diabetes Care Announces Global Integration Of The Eversense CGM System With Apple Health The Eversense CGM app has been updated globally to seamlessly integrate with Apple HealthTM, according to Ascensia Diabetes Care, a global diabetes care company that produces the CONTOUR Blood Glucose Monitoring (BGM) System portfolio and distributes […]
Roche introduces the navify brand for its digital health solutions at HLTH 2022
Roche introduces the navify brand for its digital health solutions at HLTH 2022 : Under the navify brand, Roche combines its digital health offerings while offering a variety of cutting-edge software solutions. The navify portfolio makes use of digital solutions, analytics, and data science to offer insights that solve current […]
Karyopharm and Menarini Group announce orphan drug designation by the European Commission for selinexor for the treatment of myelofibrosis
The Menarini Group, a prominent privately held international pharmaceutical company, and Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the European Commission (EC) has granted selinexor orphan Medicinal Product Designation. It is intended to be used to treat myelofibrosis (MF). In May 2022, the […]
CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology
CSL Enters Licensing Agreement with Arcturus Therapeutics : Today, CSL Limited reports that its subsidiary, CSL Seqirus, has collaborated and licenced its late-stage self-amplifying mRNA (sa-mRNA) vaccine platform technology to Arcturus Therapeutics Holdings Inc (or “Arcturus Therapeutics”). Future mRNA vaccines are being created by Arcturus Therapeutics. It has created a […]
Invitae study shows therapy informed by genetic testing reduces seizures in some patients with epilepsy
Invitae study shows therapy informed by genetic testing reduces seizures in some patients with epilepsy Leading medical genetics business Invitae has released the findings of a study that details the steps clinicians take when patients with epilepsy have a positive diagnostic genetic test result. According to research published in JAMA […]
Boehringer Ingelheim Extends the Use of Medidata Rave for Electronic Data Capture in Clinical Trials
Electronic Data Capture in Clinical Trials Boehringer Ingelheim and Medidata, a Dassault Systems firm, today announced a five-year extension of their partnership in the broader field of electronic data collection. The new arrangement includes myMedidata, Medidata’s portfolio of cutting-edge patient-facing technologies aimed at boosting patient centricity and diversity in decentralised […]
Exscientia wins the Prix Galien USA 2022 Digital Health Solution Award
Exscientia plc is proud to announce that its AI-based platform for precision medicine has received the Prix Galien USA 2022 Best Digital Health Solution. At the Prix Galen Forum in New York on Thursday, the prize was presented. The Prix Galien, which honours superiority in scientific discoveries that advance human […]
Can The Metaverse Drive The Metamorphosis Of Healthcare?
It is appropriate that the parallel realities offered by the metaverse paint an upbeat future while reality post-Covid-19 becomes more and more burdened with economic, geopolitical, and social headwinds. A global technological gold rush has been sparked by the metaverse’s potential to revolutionise entertainment, employment, commerce, and social life; yet, […]
INOVIO Provides Update on COVID-19 Heterologous Booster Vaccine Candidate, INO-4800
INO-4800 was going to be developed as a COVID-19 heterologous booster vaccine, but INOVIO, a biotechnology company specialising in the development and commercialization of DNA medicines to help treat and prevent infectious diseases, cancer, and diseases linked to HPV, has announced today that it has stopped doing so. The choice […]
